⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL564450 | 0.91 | — | — | |
| SCHEMBL2509868 | 0.88 | — | — | |
| SCHEMBL2506865 | 0.88 | — | — | |
| SCHEMBL285503 | 0.88 | — | — | |
| SCHEMBL1829299 | 0.71 | — | — | |
| SCHEMBL173784 | 0.61 | — | — | |
| SCHEMBL3277375 | 0.59 | — | — | |
| SCHEMBL3276475 | 0.57 | — | — | |
| SCHEMBL871674 | 0.57 | — | — | |
| SCHEMBL18686 | 0.53 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814698-B2 | Methods for simultaneous leaching and extraction of precious metals | EXCIR WORKS CORP. (CA) | 2023-11-14 | — | — | US | claimed |
| EP-3808749-B1 | PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES | VERTEX PHARMA (US) | 2023-03-08 | — | — | EP | claimed |
| US-20220340998-A1 | METHODS FOR SIMULTANEOUS LEACHING AND EXTRACTION OF PRECIOUS METALS | EXCIR WORKS CORP. (CA) | 2022-10-27 | — | — | US | claimed |
| US-11427886-B2 | Methods for simultaneous leaching and extraction of precious metals | EXCIR WORKS CORP. (CA) | 2022-08-30 | — | — | US | claimed |
| EP-3808749-A1 | PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES | Vertex Pharmaceuticals Incorporated (US) | 2021-04-21 | — | — | EP | claimed |
| EP-3770148-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2021-01-27 | — | — | EP | claimed |
| EP-3418281-B1 | PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES | VERTEX PHARMA (US) | 2020-09-30 | — | — | EP | claimed |
| EP-3418281-A1 | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE FOR THE TREATMENT OF CANCER DISEASES | Vertex Pharmaceuticals Inc. (US) | 2018-12-26 | — | — | EP | claimed |
| US-20180142322-A1 | METHODS FOR SIMULTANEOUS LEACHING AND EXTRACTION OF PRECIOUS METALS | UNIVERSITY OF SASKATCHEWAN (CA) | 2018-05-24 | — | — | US | claimed |
| US-20180112289-A1 | METHODS FOR SELECTIVE LEACHING AND EXTRACTION OF PRECIOUS METALS IN ORGANIC SOLVENTS | UNIVERSITY OF SASKATCHEWAN (CA) | 2018-04-26 | — | — | US | claimed |
| WO-2014081689-A1 | COMPOUNDS USEFUL AS INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-05-30 | — | — | WO | claimed |
| US-7465748-B2 | Antiherpesvirus drugs; great pharmacokinetics, good antivirus activity when administered orally at a low dose, high safety profile, less mutagenic concerns; N-(2,6-dimethylphenyl)-N-(2-{[4-(1,3-oxazol-4-yl)phenyl]amino)-2-oxoethyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide | ASTELLAS PHARMA INC. (JP) | 2008-12-16 | — | — | US | claimed |
| US-20060229295-A1 | Amide derivatives | ASTELLAS PHARMA INC.AND RATIONAL DRUG DESIGN (JP) | 2006-10-12 | — | — | US | claimed |
| US-20060211697-A1 | 2-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC. | 2006-09-21 | — | — | US | claimed |
| CN-1832930-A | Amide derivative | YAMANOUCHI PHARMA CO LTD (JP) | 2006-09-13 | — | — | CN | claimed |
| EP-1652843-A1 | AMIDE DERIVATIVES | Astellas Pharma Inc. (JP) | 2006-05-03 | — | — | EP | claimed |
| US-6358982-B1 | FOR THERAPY OF CENTRAL NERVOUS SYSTEM (CNS) DISORDERS | ELI LILLY AND COMPANY | 2002-03-19 | — | — | US | claimed |
| EP-1100497-A4 | HETEROCYCLYL SULPHONAMIDE DERIVATIVES | LILLY CO ELI (US) | 2001-09-12 | — | — | EP | claimed |
| EP-1100497-A1 | HETEROCYCLYL SULPHONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2000006158-A1 | HETEROCYCLYL SULPHONAMIDE DERIVATIVES | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | claimed |